Spruce Biosciences, Inc.
SPRB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4,911 | $10,089 | $0 | $0 |
| % Growth | -51.3% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $4,911 | $10,089 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| R&D Expenses | $46,418 | $49,432 | $35,198 | $30,698 |
| G&A Expenses | $14,644 | $12,650 | $12,085 | $11,368 |
| SG&A Expenses | $14,644 | $12,650 | $12,085 | $11,368 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $61,062 | $62,082 | $47,283 | $42,066 |
| Operating Income | -$56,151 | -$51,993 | -$47,283 | -$42,066 |
| % Margin | -1,143.4% | -515.3% | – | – |
| Other Income/Exp. Net | $3,115 | $4,074 | $1,103 | -$226 |
| Pre-Tax Income | -$53,036 | -$47,919 | -$46,180 | -$42,292 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$53,036 | -$47,919 | -$46,180 | -$42,292 |
| % Margin | -1,079.9% | -475% | – | – |
| EPS | -96.75 | -93 | -72 | -68.25 |
| % Growth | -4% | -29.2% | -5.5% | – |
| EPS Diluted | -96.75 | -93 | -72 | -68.25 |
| Weighted Avg Shares Out | 536 | 501 | 612 | 607 |
| Weighted Avg Shares Out Dil | 536 | 501 | 612 | 607 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,422 | $4,557 | $1,523 | $119 |
| Interest Expense | $307 | $483 | $420 | $345 |
| Depreciation & Amortization | $46 | $70 | $74 | $68 |
| EBITDA | -$52,683 | -$47,366 | -$45,686 | -$41,879 |
| % Margin | -1,072.8% | -469.5% | – | – |